HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Consumption of a high-fat diet rapidly exacerbates the development of fatty liver disease that occurs with chronically elevated glucocorticoids.

Abstract
Chronically elevated glucocorticoids (GCs) and a high-fat diet (HFD) independently induce insulin resistance, abdominal obesity, and nonalcoholic fatty liver disease (NAFLD). GCs have been linked to increased food intake, particularly energy-dense "comfort" foods. Thus we examined the synergistic actions of GCs and HFD on hepatic disease development in a new rodent model of chronically elevated GCs. Six-week-old male Sprague-Dawley rats received exogenous GCs, via subcutaneous implantation of four 100-mg corticosterone (Cort) pellets, to elevate basal GC levels for 16 days (n = 8-10 per group). Another subset of animals received wax pellets (placebo) to serve as controls. Animals from each group were randomly assigned to receive a 60% HFD or a standard high-carbohydrate (13% fat and 60% carbohydrate) diet. Cort + HFD resulted in central obesity, despite a relative weight loss, a 4-fold increase in hepatic lipid content, hepatic fibrosis, and a 2.8-fold increase in plasma alanine aminotransferase levels compared with placebo + chow controls. Hepatic injury developed independent of inflammation, as plasma haptoglobin levels were reduced with Cort treatment. Insulin resistance and hepatic steatosis occurred with Cort alone; these outcomes were further exacerbated by the HFD in the presence of elevated Cort. In addition to fatty liver, the Cort + HFD group also developed severe insulin resistance, hyperinsulinemia, hyperglycemia, and hypertriglyceridemia, which were not evident with HFD or Cort alone. Thus a HFD dramatically exacerbates the development of NAFLD and characteristics of the metabolic syndrome in conditions of chronically elevated Cort.
AuthorsAnna M D'souza, Jacqueline L Beaudry, Andrei A Szigiato, Stephen J Trumble, Laelie A Snook, Arend Bonen, Adria Giacca, Michael C Riddell
JournalAmerican journal of physiology. Gastrointestinal and liver physiology (Am J Physiol Gastrointest Liver Physiol) Vol. 302 Issue 8 Pg. G850-63 (Apr 15 2012) ISSN: 1522-1547 [Electronic] United States
PMID22268100 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • CD36 Antigens
  • Ceramides
  • Fatty Acids, Nonesterified
  • Glucocorticoids
  • Protein Kinase C-delta
  • Protein Kinase C-epsilon
  • Corticosterone
Topics
  • Adipose Tissue (pathology)
  • Adrenal Glands (pathology)
  • Animals
  • Atrophy
  • Blotting, Western
  • Body Weight (physiology)
  • CD36 Antigens (metabolism)
  • Cell Membrane (enzymology)
  • Ceramides (metabolism)
  • Circadian Rhythm (drug effects)
  • Corticosterone (blood, pharmacology)
  • Cytosol (enzymology)
  • Diet, High-Fat (adverse effects)
  • Fatty Acids, Nonesterified (blood)
  • Fatty Liver (chemically induced, pathology)
  • Glucocorticoids (metabolism, pharmacology)
  • Insulin Resistance
  • Lipid Metabolism (drug effects)
  • Liver (metabolism, pathology)
  • Liver Cirrhosis (pathology)
  • Male
  • Muscle, Skeletal (pathology)
  • Portal Vein (metabolism)
  • Protein Kinase C-delta (metabolism)
  • Protein Kinase C-epsilon (metabolism)
  • Rats
  • Rats, Sprague-Dawley
  • Real-Time Polymerase Chain Reaction

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: